Search

Search Constraints

You searched for: Author/Creator Smith, Matthew R.

Search Results

21. MP27-05 EFFICACY AND SAFETY OF DAROLUTAMIDE IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH AND WITHOUT PRIOR LOCAL THERAPY WITH RADICAL PROSTATECTOMY OR RADIOTHERAPY. (May 2022)

24. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial. Issue 3 (March 2022)

25. Radiographic progression by Prostate Cancer Working Group (PCWG)‐2 criteria as an intermediate endpoint for drug development in metastatic castration‐resistant prostate cancer. (17th July 2014)

26. Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. (28th November 2017)

29. The Evolution of Lightning Flash Density, Flash Size, and Flash Energy During Hurricane Dorian's (2019) Intensification and Weakening. Issue 8 (20th April 2021)